Tirzepatide emerges a groundbreaking pharmaceutical agent for individuals facing type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://idavfdf584289.ttblogs.com/20477215/tirzepatide-a-new-frontier-in-diabetes-treatment